Mature Results of a Phase I SRS Dose Escalation Trial in Combination with an EGFR Inhibitor Gefitinib in Recurrent Malignant Gliomas and a Follow-up Pilot Trial with an EGFR and VEGFR Dual Inhibitor
Changhu Chen, MD, from the University of Colorado Denver discusses the mature results of a phase I SRS dose escalation trial in combination with an EGFR inhibitor gefitinib in recurrent malignant gliomas and a follow-up pilot trial with an EGFR and VEGFR dual inhibitor. Before he goes into detail about these trials, their methods and results, he gives some background about recurrent malignant gliomas and their treatment.
About the speaker
Changhu Chen, MD
University of Colorado Denver, USA
Novalis LINAC Radiosurgery and Radiotherapy for Chordomas and Chondrosarcomas of the Skull Base
Novalis Stereotactic Radiation Therapy for Gamma-Knife-Untreatable Meningiomas
Analysis of Patients Treated with Novalis Radiosurgery after Surgical Resection As Post-Op Adjuvant Therapy for Recurrent or Residual Meningioma
Integration of Novalis Tx with RapidArc for Stereotactic Intracranial Radiosurgery
Radiosurgery with a Higher Tumor Dose without a Higher Normal Tissue gEUD
Radiosurgical Third Ventriculostomy????
Shaped Beam Radiosurgery for Malignant Gliomas
Stereotactic Radiotherapy (SRT) for Optic Nerve Sheath Meningiomas (ONSM)
Interested in watching this clinical talk? Please click on the button “WATCH Video” to enter your contact details and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Video related updates.WATCH Video
Thank you for watching! Please enter your contact details below to continue watching and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Circle video related updates.Watch video No Thanks
Already Novalis Circle Member?Member Login